Cargando…

An augmented patient-specific approach to administration of contrast agent for CT renal angiography

PURPOSE: This hybrid retrospective and prospective study performed on 200 consecutive patients undergoing renal CTA, investigates the opacification of renal vasculature, radiation dose, and reader confidence. MATERIALS AND METHODS: 100 patients were assigned retrospectively to protocol A and the oth...

Descripción completa

Detalles Bibliográficos
Autores principales: Saade, Charbel, Hamieh, Nadine, Deeb, Ibrahim Al-Sheikh, Haddad, Maurice, Abi-Ghanem, Alain S., Ghieh, Diamond, El-Merhi, Fadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844352/
https://www.ncbi.nlm.nih.gov/pubmed/31268642
http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0366
_version_ 1783468418930835456
author Saade, Charbel
Hamieh, Nadine
Deeb, Ibrahim Al-Sheikh
Haddad, Maurice
Abi-Ghanem, Alain S.
Ghieh, Diamond
El-Merhi, Fadi
author_facet Saade, Charbel
Hamieh, Nadine
Deeb, Ibrahim Al-Sheikh
Haddad, Maurice
Abi-Ghanem, Alain S.
Ghieh, Diamond
El-Merhi, Fadi
author_sort Saade, Charbel
collection PubMed
description PURPOSE: This hybrid retrospective and prospective study performed on 200 consecutive patients undergoing renal CTA, investigates the opacification of renal vasculature, radiation dose, and reader confidence. MATERIALS AND METHODS: 100 patients were assigned retrospectively to protocol A and the other 100 were allocated prospectively to protocol B. Both protocols implemented a contrast material and saline flow rate of 4.5 mL/sec. Protocol A utilized a 100 mL of low-osmolar nonionic IV contrast material (Ioversol 350 mg I/mL) while protocol B employed a patient-tailored contrast media formula using iso-osmolar non-ionic (Iodixanol 320 mg I/mL). RESULTS: Arterial opacification in the abdominal aorta and in the bilateral main proximal renal arteries demonstrated no statistical significance (p>0.05). Only the main distal renal artery of the left kidney in protocol B was statistically significant (p<0.046). In the venous circulation, the IVC demonstrated a significant reduction in opacification in protocol B (59.39 HU ± 19.39) compared to A (87.74 HU ± 34.06) (p<0.001). Mean CNR for protocol A (22.68 HU ± 13.72) was significantly higher than that of protocol B (14.75 HU ± 5.76 p< 0.0001). Effective dose was significantly reduced in protocol B (2.46 ± 0.74 mSv) compared to A (3.07 ± 0.68 mSv) (p<0.001). Mean contrast media volume was reduced in protocol B (44.56 ± 14.32 mL) with lower iodine concentration. ROC analysis demonstrated significantly higher area under the ROC curve for protocol B (p< 0.0001), with inter-reader agreement increasing from moderate to excellent in renal arterial visualization. CONCLUSION: Employing a patient-tailored contrast media injection protocol shows a significant refinement in the visualization of renal vasculature and reader confidence during renal CTA.
format Online
Article
Text
id pubmed-6844352
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Sociedade Brasileira de Urologia
record_format MEDLINE/PubMed
spelling pubmed-68443522019-12-05 An augmented patient-specific approach to administration of contrast agent for CT renal angiography Saade, Charbel Hamieh, Nadine Deeb, Ibrahim Al-Sheikh Haddad, Maurice Abi-Ghanem, Alain S. Ghieh, Diamond El-Merhi, Fadi Int Braz J Urol Original Article PURPOSE: This hybrid retrospective and prospective study performed on 200 consecutive patients undergoing renal CTA, investigates the opacification of renal vasculature, radiation dose, and reader confidence. MATERIALS AND METHODS: 100 patients were assigned retrospectively to protocol A and the other 100 were allocated prospectively to protocol B. Both protocols implemented a contrast material and saline flow rate of 4.5 mL/sec. Protocol A utilized a 100 mL of low-osmolar nonionic IV contrast material (Ioversol 350 mg I/mL) while protocol B employed a patient-tailored contrast media formula using iso-osmolar non-ionic (Iodixanol 320 mg I/mL). RESULTS: Arterial opacification in the abdominal aorta and in the bilateral main proximal renal arteries demonstrated no statistical significance (p>0.05). Only the main distal renal artery of the left kidney in protocol B was statistically significant (p<0.046). In the venous circulation, the IVC demonstrated a significant reduction in opacification in protocol B (59.39 HU ± 19.39) compared to A (87.74 HU ± 34.06) (p<0.001). Mean CNR for protocol A (22.68 HU ± 13.72) was significantly higher than that of protocol B (14.75 HU ± 5.76 p< 0.0001). Effective dose was significantly reduced in protocol B (2.46 ± 0.74 mSv) compared to A (3.07 ± 0.68 mSv) (p<0.001). Mean contrast media volume was reduced in protocol B (44.56 ± 14.32 mL) with lower iodine concentration. ROC analysis demonstrated significantly higher area under the ROC curve for protocol B (p< 0.0001), with inter-reader agreement increasing from moderate to excellent in renal arterial visualization. CONCLUSION: Employing a patient-tailored contrast media injection protocol shows a significant refinement in the visualization of renal vasculature and reader confidence during renal CTA. Sociedade Brasileira de Urologia 2019-01-29 /pmc/articles/PMC6844352/ /pubmed/31268642 http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0366 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Saade, Charbel
Hamieh, Nadine
Deeb, Ibrahim Al-Sheikh
Haddad, Maurice
Abi-Ghanem, Alain S.
Ghieh, Diamond
El-Merhi, Fadi
An augmented patient-specific approach to administration of contrast agent for CT renal angiography
title An augmented patient-specific approach to administration of contrast agent for CT renal angiography
title_full An augmented patient-specific approach to administration of contrast agent for CT renal angiography
title_fullStr An augmented patient-specific approach to administration of contrast agent for CT renal angiography
title_full_unstemmed An augmented patient-specific approach to administration of contrast agent for CT renal angiography
title_short An augmented patient-specific approach to administration of contrast agent for CT renal angiography
title_sort augmented patient-specific approach to administration of contrast agent for ct renal angiography
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844352/
https://www.ncbi.nlm.nih.gov/pubmed/31268642
http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0366
work_keys_str_mv AT saadecharbel anaugmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT hamiehnadine anaugmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT deebibrahimalsheikh anaugmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT haddadmaurice anaugmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT abighanemalains anaugmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT ghiehdiamond anaugmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT elmerhifadi anaugmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT saadecharbel augmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT hamiehnadine augmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT deebibrahimalsheikh augmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT haddadmaurice augmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT abighanemalains augmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT ghiehdiamond augmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography
AT elmerhifadi augmentedpatientspecificapproachtoadministrationofcontrastagentforctrenalangiography